Get started
Anavex Life Sciences Corp.Anavex Life Sciences Corp.Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

AVXL trade ideas

Swing Trade Idea – AVXL Anavex Life Sciences ( NASDAQ:AVXL ) is a clinical-stage biotech developing precision medicine therapies for CNS diseases like Alzheimer’s, Rett syndrome, and Parkinson’s. Its lead drug has shown promising Phase IIb/III data in Alzheimer’s. The company holds strong IP, operates debt-free, and benefits from long-term tailwinds in neurodegenerative treatment demand and regulatory fast-track pathways. Technical Since Feb 28, AVXL has been climbing within a rising channel on increasing volume, signaling accumulation. RSI is rising but still below overbought. A breakout above $10 with strong volume could trigger a momentum leg toward $11.50–13.00. Pullbacks to $9.50–9.60 offer low-risk entries. Setup Entry: $10 Targets: 🎯 $10.50 🎯 $11.50 🛑 $9.20 Risk/Reward ratio: ⚠️ 1:3 Factors to watch this week for NASDAQ:AVXL 👉🏼 Price holding above $9.50 support and within rising channel 👉🏼 Breakout attempt above $10 with strong volume 👉🏼 Rising volume on green days (watch for volume > average ~1M) 👉🏼 RSI staying above 60 and trending toward 70 👉🏼 Reaction to any pullback – buying pressure near $9.50–9.60 = bullish confirmation
NASDAQ:AVXLLong
by Invictus744
$AVXL Potential Movement (11/11/24)Hey Traders, NASDAQ:AVXL is riding the market momentum hard this month! We’ve got a key support level at $8.10, marked by the previous higher high and break of structure—watch for a possible test here before the next leg up! On the resistance side, it’s looking so strong we’re jumping to the 1-week chart, with the previous high all the way up at $10.20. This one’s definitely one to watch as we head into Monday! As always, trade with discipline and lock in those profits! David Diz-Plin Trading
NASDAQ:AVXL
by DizPlin
$AVXL is gonna fall todayPupm&Dump trading strategy idea. $AVXL is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $23,49; stop-loss — $24,55; take-profit — $21,37. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:AVXLShort
by KozakHlib
AVXL Week 12/07/21 - 17/07/21. It is my first public analysis after having a dozen or so or private and correct analysis. I believe however I need to disclose I am not a financial advisor, however I am a investor in several of AVXL positions and have been studying this stock for a while. Anyways, in y analysis I came to spot the formation of the first smaller cup, and fibonacci regressions to predict accurately the last peak of the AVXL stock. Furthermore, in the current down correction of the market, with still strong buy technicals came to spot the formation and current development of a larger, rather shallow second upwards cup; in white. measuring and using the fundamentals values of the last 3 AVXL formations I predict the formation of a handle. bottom at the range of the dotted and solid red lines, price consolidation should happened between $24.04 - $24.62. before carrying on its upwards trend hitting the $28- $28.15 mark. depending on the height in relation to the last price peak on 9th of July which should see a new price consolidation range of roughly $28.3-$27.1 before breaking upwards in the magnitude of 410px -420px. from the this new base price, a conservative calculated peak of $29.6 but possibly as high as $32. Important to note would be whether AVXL has the ability of break the previous highest resistance level of $29.65 - 31.5. Failing to do so we could possibly see a big market reversal. plummeting AVXL to the previous base price of $20-21.5 within next week before trying to break this ceiling once gain. On the other side of the spectrum. Breaking the $31.5 resistance is unlikely to maintain these gains due to no changed fundamentals, but it would solidly the new support price at $27.2 - $27.9 and a solid base price at $25.2. before seeing further advancing into my predicted $35-33 Price consolidation at market optimal point before a change in fundamentals. This is in the form of the success of their clinical trials and pending FDA approvals, which, if continues the positive trend could see this company valuation triple over the course of a few days and its stock value (under current float outstanding) easily reach pass the 80-90 dollar mark.
NASDAQ:AVXLLong
by suikaking
Sympathy playSympathy play Anavex stock gained after favorable data from Cassava Sciences in Alzheimer’s! With a rise yesterday, Cassava Sciences extended its gains after announcement of favorable data from an open-label study in Alzheimer’s disease! The shares have been on a bullish mode for the last several days, reaching an all-time high, on encouraging data for its differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders such as Alzheimer's disease, Parkinson's disease, Rett syndrome, and other central nervous system diseases.
NASDAQ:AVXL
by AlenCiken
2
Anavex Life Sciences Corp. on Breakout Alert Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY. Short interest 12% Buy rating | $12 analysts average target
NASDAQ:AVXLLong
by DEXWireNews